HAPPEL DAVID (President & CEO) sold 1.8% of their position (12.10K shares) of SAGIMET BIOSCIENCES INC. on the open market
Open‑market sale worth $64.9K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 2/12/2026ACC: 0001104659-26-014283
DirectorOfficer· President & CEO
Since Feb 2026
-12.10K
Net shares
Net seller
$64.9K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
12.10K disposed
Non-Derivative Transactions1
Series A Common Stock
Direct
Shares
−12.10K
Price / share
$5.36
Trade value
$64.86K
% of position
1.8%
2/10/2026
689.72K→677.62K
Total
Net shares
−12.10K
Net value
-$64.86K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Series A Common Stock Direct | 2/10/2026 | S · Sale | −12.10K | $5.36 | $64.86K | 1.8% | 689.72K | 677.62K |
| Total | −12.10K | -$64.86K | ||||||
Derivative Transactions0
No derivative transactions reported